Media

A More Inclusive Framework for Alzheimer’s Disease

The Easton Center, ELHA Lab, UCLA Neurology, Alzheimer's Los Angeles, and community leaders are working together bridging the gap between health disparities ...

Alzheimer's and Brain Awareness Month

Alzheimer’s and Brain Awareness Month

Dr. Keith Vossel's interview with Alex Cohen about raising awareness for Alzheimer’s and Brain Awareness Month with exciting updates in the Alzheimer’s field.

An In-Depth Interview on Various Neurodegenerative Diseases

Dr. Keith Vossel was interviewed by Dr. Marc Siegel from Doctor Radio/Sirius XM about a wide spectrum of neurodegenerative diseases, including ...

Axonal Swelling in Alzheimer’s Disease and New Tests May Improve the Certainty of Alzheimer’s Diagnosis

Can the New Alzheimer’s Drug Slow the Progression of the Disease?

Controversial New Alzheimer's Drug

Did Aphasia Influence Bruce Willis’ Career Decisions? Every Case is Unique

Donanemab, Eli Lilly’s New Groundbreaking Alzheimer’s Drug

Dr. Keith Vossel, Director of the UCLA Easton Center, was interviewed by MarketWatch about Eli Lilly's new Alzheimer’s medication, donanemab.

Dr. Vossel Discussed the Work of the Easton Center on "Radio Night Live" AM970 in NY

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity

Eisai’s Approach To the New Alzheimer’s Drug

Empowering Aging Latinos through Alzheimer’s Community Outreach

FDA Approved the New Alzheimer's Drug, Marketed as Leqembi

Future Data Will Determine the Effectiveness of the New Alzheimer’s Drug

Dr. Keith Vossel was quoted in a San Francisco Chronicle article about Lecanemab.......